September 25, 2020
Innovations in Screening Options for Barrett’s Esophagus
Could your chronic heartburn put you at risk for Esophageal cancer?
According to recent studies, chronic heartburn affects almost 60 million Americans, and if left untreated and becomes severe, has been linked with a condition that may lead to esophageal cancer.
About one in 10 patients who have chronic uncontrolled reflux disease can develop Barrett’s esophagus after as early as about five years. Barrett’s esophagus is a condition in which the flat pink lining of the esophagus becomes damaged by acid reflux, which causes the lining to thicken and become red, often resulting in cellular changes that can lead to dysplasia.
EsoGuard is an esophageal DNA test for Barrett’s esophagus and other known precursors to Esophageal cancer. Doctors perform a non-invasive, office-based procedure to safely and simply sample cells from the esophagus in order to be sent for analysis. Studies have found that it is well tolerated in patients and provides greater than 90% sensitivity and specificity compared to endoscopy.
Stay tuned for the latest innovations in health and nutrition.
Olga Villaverde is joined by Dr. Maria-Amelia Rodrigues, a Radiation Oncologist with Miami Cancer Institute, for a closer look at an innovative breast cancer radiation therapy.
We are joined by Dr. Sivan Kinberg, Director of the Pediatric Intestinal Rehabilitation Center at Columbia University in New York, to learn about the importance of fatty acids and calories in parenteral nutrition.